Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
Earnings News on Dr Reddys Laboratories
Dr Reddy's Q4 cons net jumps 67% to Rs 571 cr
3.13 pm | 14 May 2013 | Source: Moneycontrol.com
Hyderabad-based Dr Reddy's fourth quarter consolidated net profit increased 67 percent year-on-year to Rs 571 crore, helped by surge in other income a...
Dr Reddy's Q3 cons net profit down 29% at Rs 363cr
2.20 pm | 14 Feb 2013 | Source: Moneycontrol.com
Dr Reddy's Laboratories missed street expectations on Thursday as third quarter consolidated net profit declined a higher-than-expected 29 percent yea...
Dr Reddy's Q3 revenue seen up 5% at Rs 2,913cr
6.34 pm | 13 Feb 2013 | Source: Moneycontrol.com
Strong growth in US generic drug sales will continue to drive revenue growth for Dr Reddy's Laboratories. The pharma major will report its third quart...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.